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Abstract
Hepatitis C is a viral infection that appears as a result of the Hepatitis C Virus
(HCV), and it has been recognized as the main reason for liver diseases. HCV
incidence is growing as an important issue in the epidemiology of infectious dis-
eases. In the present study, a mathematical model is employed for simulating
the dynamics of HCV outbreak in a population. The total population is divided
into five compartments, including unaware and aware susceptible, acutely and
chronically infected, and treated classes. Then, a Lyapunov-based nonlinear
adaptive method is proposed for the first time to control the HCV epidemic
considering modelling uncertainties. A positive definite Lyapunov candidate
function is suggested, and adaptation and control laws are attained based on
that. The main goal of the proposed control strategy is to decrease the pop-
ulation of unaware susceptible and chronically infected compartments by pur-
suing appropriate treatment scenarios. As a consequence of this decrease in
the mentioned compartments, the population of aware susceptible individuals
increases and the population of acutely infected and treated humans decreases.
The Lyapunov stability theorem and Barbalat’s lemma are employed in order
to prove the tracking convergence to desired population reduction scenarios.
Based on the acquired numerical results, the proposed nonlinear adaptive con-
troller can achieve the above-mentioned objective by adjusting the inputs (rates
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of informing the susceptible people and treatment of chronically infected ones)
and estimating uncertain parameter values based on the designed control and
adaptation laws, respectively. Moreover, the proposed strategy is designed to
be robust in the presence of different levels of parametric uncertainties.
Keywords: Nonlinear adaptive control, Hepatitis C epidemic, Infectious
disease dynamics, Uncertainty and stability, Lyapunov stability theorem,
Robust performance.
1. Introduction
The Hepatitis C Virus (HCV) is a blood-borne virus identified as the main
cause of the liver disease [1, 2, 3]. Globally, about three percent of the world
population (170 million) are dealing with the HCV and 71 million people have
chronic hepatitis C infection [1, 4, 5, 6]. Several studies showed that the chronic
stage of HCV will develop the cirrhosis and liver cancer in the case of no treat-
ment and approximately 339 thousands people die every year due to these dis-
eases[1, 7]. Despite previously mentioned statistics which makes HCV infection
as one of the important health threats, this disease received little attention es-
pecially in the regions with higher rate of infectiousness [4].
Although fatigue and jaundice were mentioned as symptoms of the HCV, but
this disease often has no considerable symptom, even in the advanced stages.
This is the reason that the HCV outbreak is called ”the silent epidemic” [4, 8].
Several different ways were reported for HCV prevalence, which include shar-
ing injection equipments, unsafe sexual contacts, inadequately sterilization of
syringes and needles especially for health-care personnel and transfusion of pol-
luted blood [1, 9]. Even though these are the main causes of HCV epidemic,
but some other reasons may also be critical in some societies based on special
conditions. For instance in developed countries, since there is precise control on
the blood transfusion, the importance of injecting drug use in transmission of
the disease has increased compared to the transfusion of polluted blood and its
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products [2, 9].
Natural cure at the chronic stage of HCV is not common, but it can happen
for about 10-15% of patients that the RNA of HCV is indistinguishable in their
serum [5, 6]. For the rest of patients (80-85 %) that the HCV could not be
healed by their immune system response, some drug therapy regimes should be
employed. Hepatitis C drugs have recently had some developments. Available
safe, highly effective and endurable combinations of oral antivirals that act di-
rectly, have currently developed for this disease [4, 10]. Although vaccination
is the vital way of controlling different viral diseases, but unfortunately there
is no vaccine for the HCV yet [5]. Therefore, preventing this disease has an
important role in stopping the extension of the its epidemic.
In the present work, a nonlinear adaptive method is developed for treatment
and control of the HCV epidemic. For this purpose, the recently published
nonlinear HCV epidemiological model in [4] is employed and different parametric
uncertainties are taken into account, despite the previous optimal strategies [4].
The main goal of the proposed control scheme is the population decrease in
the unaware susceptible and chronically infected compartments in the existence
of parametric uncertainties. Accordingly, two control inputs (efforts to inform
susceptible individuals and treatment rate) are employed to track descending
desired populations of the previously mentioned compartments. The asymptotic
stability and tracking convergence of the closed-loop system having uncertainties
are proven using the Lyapunov stability theorem and the Barbalat’s lemma.
Innovations of this research are as follows:
• For the first time a nonlinear adaptive method is developed to control
the HCV epidemic by defining a novel Lyapunov function candidate that
provides the tracking convergence proof.
• Due to the lack of accurate information about HCV model parameters in
each society, parametric uncertainty is taken into account in this research
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for the first time, and the defined control objectives are achieved in the
presence of these inaccuracies.
• In all of the previous studies that have been conducted on the control of
the HCV outbreak, populations of some undesired compartments at the
end of investigation period were considered as the criterion for designing
control inputs [11, 12, 4, 13, 14]. However, in the present work for the first
time, the populations of two unawared susceptible and chronically infected
classes during the entire treatment period are considered as the criterion
and control inputs are designed in a way to track desired values instead
of focusing on their final populations at the end of process.
The rest of this chapter is organized as follows. In Sec. 2, related research
work will be explained. Description of the dynamic model and the proposed
control scheme will be presented in Sec. 3 and Sec. 4, respectively. Results of
simulations will be depicted and discussed in Sec. 5, and the concluding remarks
will be mentioned in Sec. 6.
2. Related research work
Previous related studies are presented in this section and divided into three
parts, including mathematical modeling, and Optimal control for HCV and
adaptive control strategies for different biological systems.
Several analytical analyses were conducted on the dynamic modeling of the
HCV epidemic which are presented here. Martcheva and Chavez [15] presented a
simple mathematical model with three compartmental variables including sus-
ceptible, acutely infected and chronically infected. They considered different
epidemiological observations in the model. Yuan and Yang [8] added the ex-
posed class to the previous model [15]. They considered that the susceptible
individuals transmit to the exposed compartment in the case of having contact
with the infected compartments. Zhang and Zhou [5] added a new term in the
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model of Yuan and Yang [8], which denotes the death rate due to the HCV. Hu
and Sun [16] proposed another epidemiological model for the HCV with four
classes in which the recovered compartment was taken into account for the first
time. Naturally the recovered people transmit to this class from the acutely
infected and chronically infected compartments and become immune against
this. Ainea et al. [17] extended the previous model [16] by adding the exposed
class. Both of these models [16] and [17] considered the HCV disease-induced
death rate for both acutely-infected and chronically infected classes. Shen et al.
[18] proposed a dynamical model with six classes including susceptible, exposed,
acutely infected, chronically infected, treated and recovered populations. They
propounded treatment influence for the first time and classified treated people
in the distinct class. Shi and Cui [19] improved the model in [18] and divided the
treated class into two different classes by defining the treatment for chronical
infection and awareal reinfection.
Some researches have been conducted for optimal control of the HCV out-
break. Okosun [11] employed a SITV (susceptible, acutely infected, treated and
chronically infected) model for the HCV that was an extended form of the dy-
namics presented in [8]. This model [11] included the treatment compartment
and considered movement for susceptible, treated, and acutely and chronically
infected people among their compartments. Some time dependent optimal con-
trol strategies are proposed, in order to control the HCV disease. Cost function
is calculated for these strategies in order to evaluate effectiveness of the control
methods and select the most efficient one. Okosun and Makinde [12] employed a
SEITV (susceptible, exposed, acutely infected, treated and chronically infected)
dynamical model for the HCV outbreak considering the screening rate and drug
efficacy as control inputs for acutely and chronically infected populations and
used the Pontryagin’s Principle to solve the optimal control problem. Another
epidemiological model was investigated in [4] for the HCV outbreak in which
the susceptible class was divided into aware and unaware classes. Moreover,
they considered two control inputs including screening and treatment rates for
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the HCV epidemic model which were determined by an optimal control law.
In [4], the dynamics was formulated with the susceptibility reduction due to
the publicity and the treatment process to identify the feasible effect of public
concerns and treatment on the HCV. An optimal neuro-fuzzy strategy was also
introduced in [13] in order to control the HCV epidemic. They [13] employed
the mathematical model proposed in [12] as a deterministic model and utilized
the genetic algorithm to obtain optimal control inputs.
As described, all of previous studies on the control of HCV epidemic were
conducted on the optimal strategies. On the other hand, some other research
works were performed on the adaptive control of different diseases as presented
here. Moradi et al. [20] suggested a Lyapunov-based adaptive method to con-
trol three different hypothetical models of the cancer chemotherapy inside the
human body and compared results among these models. In the next step of this
research [21], a composite adaptive strategy has been developed for online iden-
tification of cancer parameters during the chemotherapy process. Boiroux et al.
[22] employed a model predictive controller for the type 1 diabetes’ model and
used an adaptive controller to balance the blood glucose. They determined the
model parameters based on clinical information of past patients. Aghajanzadeh
et al. [23] suggested an adaptive control strategy for hepatitis B virus infection
inside the human body by antiviral drugs. They considered model parameters
uncertainties on model parameters and employed adaptive controller to control
the dynamic despite uncertainties of the system. Sharifi and Moradi[24] de-
signed a robust scheme with adaptive gains to control the influenza epidemic,
considering its dynamic model’s uncertainties. Padmanabhan et al. [25] pro-
posed an optimal adaptive method to control the sedative drug in anesthesia
administration. They employed an integral reinforcement learning method in
order to overcome the uncertainty of parameter values.
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3. Dynamic model of hepatitis C virus epidemic
Mathematical modeling is an useful way of analysis for epidemiology of a
disease. These models have two important capabilities: 1. finding out mech-
anistic understanding of the disease, and 2. exploring potential outcomes of
the epidemic under different conditions [26]. For assessment of the proposed
method for the HCV prevalence control in a population, a nonlinear compart-
mental model is used with five different classes including unaware susceptible
(Su), aware susceptible (Sa), acutely infected (I ), chronically infected (C ) and
the treated (T ) humans [4]. The susceptible compartment is divided into two
classes, including aware and unaware people. Note that aware people have in-
formation about the HCV transmission ways and preventing methods despite
unaware population. Since there is no available vaccine for the HCV, informing
people about preventing methods is a very important way to reduce the risk of
infection for susceptible people [1]. Therefore, the unaware susceptible individ-
uals (Su) will be infected in contact with the infected population (I, C and T )
with a higher rate in comparison with the aware susceptible individuals (Sa)
[4]. Thus, the transmission rate for unaware susceptible humans (Su) should
be considered larger than this rate for aware susceptible humans (Sa) in the
dynamic model [4]. The nonlinear mathematical model of HCV epidemic is as
follows:
S˙u = b− λSu
Su
N
− (µ+ u1(t))Su + (1− q)γI
S˙a = u1(t)Su − λSa
Sa
N
− µSa + (1− p)ξT
I˙ = λSu
Su
N
+ λSa
Sa
N
− (µ+ γ)I (1)
C˙ = qγI − (µ+ u2(t) + θ)C + pξT
T˙ = u2(t)C − (µ+ ξ)T
where λSu = β(I + K1C + K2T ) and λSa = αλSu . u1 and u2 are control
inputs and defined as effort rate to inform unaware susceptible individuals and
treatment rate for chronically infected class, respectively. N denotes the total
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population and will be calculated as:
N = Su + Sa + I + C + T (2)
The population of unaware susceptible (Su) increases with the rate of b.
Unaware and aware susceptible individuals are also infected in contact with
acutely and chronically infected and treated individuals at the rates of λSu and
λSa , respectively. Infectiousness rate for acutely infected people is higher than
chronically infected individuals, and the treated people have the lowest rate;
thus, it is assumed that K1 > K2 [4, 5]. The total population (N ) decreases
with two different rates µ and θ, where µ denotes the rate of natural death
that decreases populations of different compartments. However, θ is the rate
of HCV induced death and decreases the population of the chronically infected
compartment (C ).
During the acute stage (I ), the HCV could have different behaviors for each
patient based on his/her immune system response. For 15 to 25% of cases in this
stage, the RNA of HCV becomes indistinguishable in their blood serum and the
ALT level returns to the normal range. This observation is defined by the term
(1 − q)γI in the proposed HCV dynamics [4, 6]. Approximately, the immune
system in 75-85% of the patients could not remove the hepatitis C virus in the
acute stage and their disease becomes advanced to the chronic stage. Note that
if the HCV RNA reamins in the patient’s blood for at least six months after
onset of acute infection, the chronic level of the disease will appear which is
defined by the term qγI in Eq. (1) [5, 6]. Finally, the defeat in the treatment
process is defined by the term p. The treated population decreases by the rate
of ξT and join the chronic class by the rate of pξT in the case of treatment de-
feat and the rest of this population (1− p)ξT will join aware susceptible class if
the treatment be successful. The schematic diagaram of the proposed nonlinear
dynamics of the HCV epidemic is depicted in the Fig. 1 and descriptions of the
parameters are presented in Table 1 [4].
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Figure 1: Schematic diagram of transition among different classes of HCV epidemic
Table 1: Parameters of the mathematical model of the HCV (1) [4]
Parameter Description
b Rate of birth
µ Rate of death
β Transmission coefficient
K1 Chronic stage infectiousness relative to acute stage
K2 Treated individuals’ infectiousness relative to acute ones
α Rate of being infected for aware people relative to unaware ones
γ Leaving rate of acutely infected class
q Progressing proportion from acute stage to chronic one
ξ Transferring rate from treated class to other ones
p Moving back proportion from treated class to chronic one
θ HCV induced death rate
9
4. Nonlinear adaptive controller formulation for epidemiology of HCV
In the present section, a new nonlinear adaptive controller is formulated for
uncertain hepatitis C virus epidemic. The main purpose of the control method
is to minimize the populations of unaware susceptible (Su) and chronically in-
fected (C ) classes. Two control inputs u1(t) and u2(t) are considered in order
to reach this objective. u1(t) denotes the effort rate to inform the susceptible
individuals from the HCV by media publicity, educational campaigns, public
service advertising and so on, and u2(t) is employed to reflect the rate of treat-
ment on chronically infected individuals [4].
Using the above-mentioned control inputs, the populations of unaware sus-
ceptible (Su) and chronically infected (C ) classes will decrease by tracking some
desired values. Moreover, due to decrease of the mentioned components, the
number of aware susceptible (Sa) and treated (T ) individuals will increase and
decrease, respectively. The Lyapunov theorem is employed to prove stability
of the closed-loop system. In addition, some adaptation laws are defined in
order to update estimated parameters of the system to guarantee the stability
and robustness of the system against uncertainties of the dynamic model. A
conceptual diagram of the proposed nonlinear feedback controller with adaptive
scheme is illustrated in Fig. 2.
4.1. Nonlinear adaptive control laws
Control inputs (u1(t), u2(t)) could be calculated using dynamics of the un-
aware susceptible and chronically infected compartments from Eq. (1) as:
u1 = − S˙u
Su
+
b
Su
− β
N
(I +K1C +K2T )− µ+ (1− q)γ I
Su
(3)
u2 = − C˙
C
+ qγ
I
C
− (µ+ θ) + pξ T
C
(4)
Property. The right-hand sides of Eqs. (3) and (4) can be linearly parameter-
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Figure 2: Conceptual diagram of nonlinear adaptive method developed to control the HCV
epidemic in the existence of uncertainties on parameters of the model
ized in terms of their available parameters. φ1 and φ2 are considered to be the
arbitrary variables instead of S˙u and C˙. Now the equations could be rewritten
as:
− S˙u
Su
+
b
Su
− β
N
(I +K1C +K2T )− µ+ (1− q)γ I
Su
= −φ1
Su
+ Y1θ1 (5)
− C˙
C
+ qγ
I
C
− (µ+ θ) + pξ T
C
= −φ2
C
+ Y2θ2 (6)
where Y1 and Y2 are the regressor matrices contain known functions of HCV
epidemic variables. θ1 and θ2 are parameter vectors which contain unknown
parameters of the dynamic. Eqs. (7) and (8). Accordingly, these matrices and
vectors are defined as
Y1 =
[
1
Su
− I
N
−C
N
− T
N
I
Su
−1
]
; θ1 =
[
b β βK1 βK2 (1− q)γ µ
]T
(7)
Y2 =
[
I
C
T
C
−1
]
; θ2 =
[
qγ pξ (µ+ θ)
]T
(8)
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This regressor presentation is used to summarize the equations and define
the adaptation and control laws. In order to design nonlinear control laws, two
new variables φ1 and φ2 are defined as follows:
φ1 = S˙ud − λ1S˜u (9)
φ2 = C˙d − λ2C˜ (10)
where λ1 and λ2 are the controller gains and considered to be positive and
constant. Now, the nonlinear adaptive control laws are defined as
u1 = −
˙Sud − λ1S˜u
Su
+ Y1θˆ1 (11)
u2 = − C˙d − λ2C˜
C
+ Y2θˆ2 (12)
where θˆ1 and θˆ2 are the vectors of estimated parameters.
In the next section, taking advantages of the Lyapunov stability theorem, it
will be proven that the control laws (11) and (12) together with some adapta-
tion laws, guarantee the tracking convergence, stability and robustness for the
treatment of HCV outbreak.
4.2. Stability proof and adaptation laws
The closed-loop dynamics of the system is achieved firstly by substituting
the control laws (11) and (12) into the dynamics of HCV epidemic (1):
˙˜Su + λ1S˜u
Su
= −Y1θ˜1 (13)
˙˜C + λ2C˜
C
= −Y2θ˜2 (14)
where θ˜i (for i=1, 2) is defined as θˆi − θi.
The adaptation laws are designed to update parameters’ estimation to keep
the system’s robustness against uncertainties, as
˙ˆ
θT1 = SuS˜uY1Γ1 (15)
˙ˆ
θT2 = CC˜Y2Γ2 (16)
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where Γ1 and Γ2 are the adaptation gain matrices and considered to be positive
definite.
Now, employing the Lyapunov stability theorem [27] and based on the pre-
viously derived close-loop dynamics (13)-(14) and the designed adaptation laws
(15)-(16), the tracking convergence, stability and robustness for aware suscep-
tible and chronically infected classes will be proven. With this aim, a positive
definite Lyapunov-candidate-function is selected as
V =
1
2
[S˜2u + C˜
2 + θ˜T1 Γ
−1
1 θ˜1 + θ˜
T
2 Γ
−1
2 θ˜2] (17)
The Lyapunov function’s time derivative is determined:
V˙ = S˜u
˙˜Su + C˜
˙˜C +
˙ˆ
θT1 Γ
−1
1 θ˜1 +
˙ˆ
θT2 Γ
−1
2 θ˜2 (18)
It should be mentioned that
˙˜
θ =
˙ˆ
θ because θ is constant (θ˙ is zero). By
substituting the adaptation laws (15) and (16) into (18), the time derivative of
V is simplified to:
V˙ = −λ1S˜2u − λ2C˜2 (19)
As mentioned in the previous descriptions, λ1 and λ2 are considered to be
positive; thus, the Lyapunov function’s time derivative is negative-semi-definite.
Thus, based on the Barbalat’s Lemma (described in the Appendix A) and the
Lyapunov stability theorem [27], it is proven that S˜u and C˜ converge to the zero.
In other words, employing the suggested adaptive feedback control strategy en-
sures the tracking convergence and stability (S˜u → 0 and C˜ → 0 as t→∞) in
the presence of uncertainties. Thus, the numbers of unaware susceptible (Su)
and chronically infected (C ) converge to the desired values (Su → Sud and
C → Cd).
5. Results and discussion
For effectiveness evaluation of the proposed method, some simulations are
presented in this section. Note that computer simulations have proven to be use-
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Table 2: Values of the HCV parameters in its mathematical model (1) [4]
Parameter Value
b 0.012
µ 0.006
β 0.15
K1 0.5
K2 0.2
α 0.1
γ 4
q 0.2
ξ 0.8
p 0.5
θ 0.001
ful for evaluating the spread behavior of infectious diseases [28]. In the present
study, the simulation process is performed in the Simulink-Matlab environment.
The parameters’ values of the HCV epidemic model (1) are listed in Table 2.
A small society with total population of 1310 people at the beginning of in-
vestigation is used. The following desired scenarios are considered for reduction
of unaware susceptible individuals (Sud) and treatment of chronically infected
people (Cd).
Sud = (Su0 − Suf )exp(−a1t) + Suf (20)
Cd = (C0 − Cf )exp(−a2t) + Cf (21)
where a1 and a2 are the desired population reduction rates. Su0 and Suf are
the initial and final (steady state) populations of unaware susceptible class, re-
spectively. C0 and Cf are the initial and final (steady state) populations of
chronically infected compartment, respectively.
14
Table 3: Values of parameters in the desired HCV population reduction scenarios (20) and
(21)
Parameter Value
Su0 1000
C0 100
Suf 0
Cf 0
a1 0.4
a2 0.2
The presented reduction and treatment scenarios (20) and (21) are employed
in these simulations as the desired decreasing behavior of the HCV epidemic
control. However, other continuously decreasing fashion can be used as desired
scenarios without loss of generality. Values of parameters in the desired HCV
population reduction scenarios ( 20) and (21) are listed in Table 3. These sce-
narios for unaware susceptible and chronically infected compartments are shown
in Fig. 3.
In the absence of control inputs, the HCV infection will extend in the society
based on Eq. 1. Accordingly, the treated population will decrease and reach
zero exponentially due to the lack of treatment process. In that case (no control
input), unaware and aware susceptible individuals will get the hepatitis C virus
in contact with the infected people in I and C compartments and will join
the acutely infected class (I ). Since there is no treatment for acutely infected
individuals (as seen in Eq. (1)), the HCV disease will progress and reach the
chronic stage. Thus, the population of the chronically infected compartment
(C ) will increase and the populations of all other compartments will decrease.
Figure 4 depicts the above-mentioned points about the HCV outbreak in the
case of no control input.
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Figure 3: Desired scenarios for reduction of unaware susceptible and chronically infected
compartments in the HCV epidemic
However, applying the proposed strategy based on the designed nonlinear
control laws (11) and (12) with the obtained adaptation laws (15) and (16), the
population changes in different compartments in the presence of 20% parametric
uncertainty are depicted in Fig. 5.
As seen, due to the employment of the first control input (u1), the unaware
susceptible individuals (Su) reduce and join the aware susceptible class (Sa).
Since the aware susceptible people become less infectious than unaware ones
because of the control input u1, extension of the HCV infection decreases com-
pared with the no-control-input case (shown in Fig. 4). Moreover, using the
treatment rate as the second control input (u2), the population of chronically
infected compartment (C ) decreases (Fig. 5) based on the described scenarios
(Cd in Fig. 3). Thus, the populations of unaware susceptible and chronically in-
fected classes reduce and the population of aware susceptible increases in Fig. 5,
which are in accordance with the HCV dynamics (1). Although 20% parametric
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Figure 4: Populations of (a) unaware and aware susceptible, and (b) acutely infected, chron-
ically infected and treated classes in the absence of control inputs
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Figure 5: Populations of (a) unaware and aware susceptible, and (b) acutely infected, chron-
ically infected and treated classes in the presence of control inputs (u1 and u2) based on the
proposed laws (11) and (12)
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Figure 6: Convergence of unaware susceptible and chronically infected populations (Su and
C ) to their desired values (Sud and Cd)
uncertainty is taken to account for the nonlinear model, simulation results show
that the proposed control strategy satisfied its objective which is convegence to
desired population reduction and treatment scenarios (Su → Sud and C → Cd).
Figure 6 depicts the desired and real populations of unaware susceptible and
chronically infected classes,which implies the appropriate convergence perfor-
mance using the nonlinear controller. The corresponding tracking errors are
presented in Fig. 7.
As described, two control inputs are adjusted according to the proposed
nonlinear adaptive strategy in order to prevent the HCV outbreak. The first
control input u1(t) denotes the effort rate to inform the susceptible individuals
from the HCV and the second one u2(t) is the treatment rate for chronically in-
fected individuals. These control inputs are considered to be normalized in Eq.
(1) to be in the range of [0,1]. The obtained values for these inputs using the
proposed control strategy are shown in Fig. 8, which satisfy the physiological
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Figure 7: Tracking errors between the desired and real values of unaware susceptible and
acutely infected compartments
constraint (u1 ∈ [0, 1]). This implies that the considered desired scenarios (20)
and (21) for reduction of unaware susceptible and chronically infected compart-
ments comply with the control input limitations. Figure 9 illustrates the tuning
of estimated parameters (θˆ1 and θˆ2) based on the designed adaptation laws (15)
and (16) in the presence of 20% uncertainty.
5.1. System response to different uncertainty levels
In this section, effects of different uncertainty levels are investigated for the
HCV epidemic dynamics. For this purpose, 50%, 70% and 90% uncertainties
are considered on the initial guess of parameters in θ1 and θ2 (defined in Eqs.
(7) and (8)). Performance of the adaptation laws (15) and (16) on tuning of
estimated model parameters is investigated in Fig. 10. As discussed and proven
in Sec. 4, these adaptation laws guarantee that the estimation errors of the
HCV dynamic parameters remain bounded against different uncertainty levels.
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Figure 8: Control inputs (u1 and u2) during the treatment period of HCV epidemic
Figure 11 shows the population errors of unaware susceptible and chronically
infected classes in tracking their desired value (S˜u = Su−Sud and C˜ = C−Cd).
As observed in Fig. 11 the increment of parametric uncertainties, increases
the magnitude of errors (S˜u and C˜) and their initial variations. However, after
a period of time (about 0.2 year), the errors magnitudes has reached zero, which
means that the tracking convergence has been achieved for different values of
uncertainties. In other words, the population of unaware susceptible and chron-
ically infected compartments converged to their desired values (Su → Sud and
C → Cd) in the existence of different levels of uncertainty.
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Figure 9: Estimation of parameters in (a) θ1 and (b) θ2 during the treatment period based
on the adaptation laws (15) and (16), respectively
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Figure 10: Adaptation of (a) θ1(1) and (b) θ2(1) using Eqs. (15) and (16), respectively, for
different uncertainty levels
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Figure 11: The difference between (a) unaware susceptible population and its desired value
(S˜u = Su − Sud ) and (b) chronically infected population and its desired value (C˜ = C − Cd)
for different parametric uncertainty levels
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6. Conclusion
In the present study, a new nonlinear adaptive strategy was developed to
control the hepatitis C virus epidemic based on a mathematical model having
uncertainties. For the first time, an adaptive feedback controller was employed
to decrease the populations of unaware susceptible and chronically infected com-
partments based on the desired scenarios. Two control inputs were employed
for this goal. The first one u1(t) is the effort rate to inform the susceptible
individuals from the HCV and the second one u2(t) is the rate of treatment
for chronically infected people. The Lyapunov stability theorem and the Bar-
balat’s lemma were used to prove the tracking convergence to desired treatment
scenarios. The proposed control laws and adaptation laws provided the sta-
bility of the closed-loop HCV epidemic system in the presence of parametric
uncertainties. Results of numerical simulations showed that by adjusting the
control inputs and the estimated parameters based on this strategy, number of
the unaware susceptible and chronically infected individuals are decreased. As a
result, population of the aware susceptible was increased and population of the
acutely infected and treated classes reached out to zero at the end of process.
Moreover, the obtained results implied that the tracking convergence is achieved
for a wide range of uncertainties. Designing optimal trajectories and employing
unstructured uncertainties can be considered as the next steps of this research
in the future.
Appendix A. Barbalat’s lemma
The Lyapunov function V (S˜u, C˜, θ˜1, θ˜2) in (17) is positive definite and its
time derivative (V˙ (S˜u, C˜)) in (19) is negative semi definite. Thus, based on the
Lyapunov stability theorem [27], V is bounded and it is concluded that S˜u, C˜,
θ˜1 and θ˜2 remain bounded.
25
Barbalat’s lemma: if g is a uniformly continues function and limt→∞
∫ t
0
g(η)dη
exists and has a finite value, it is guaranteed that [27]:
lim
t→∞ g(t) = 0 (A.1)
In order to use this lemma for the HCV controlled system, g(t) is considered
to be -V˙ :
g(t) = −V˙ = λ1S˜2u + λ2C˜2 (A.2)
By integrating both sides of (A.2), one can write:
V (0)− V (∞) = lim
t→∞
∫ t
0
g(η)dη (A.3)
Since V˙ is negative, V (0) is larger than V (∞) and V (0)−V (∞) ≥ 0. More-
over, as mentioned previously, V is bounded based on the Lyapunov stability
theorem . Thus, limt→∞
∫ t
0
g(η)dη in (A.3) exists and has a bounded value.
Therefore, it concluded using the Barbalat’s lemma that:
lim
t→∞ (λ1S˜
2
u + λ2C˜
2) = 0 (A.4)
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